Interna Therapeutics
PrivateLast Round
Early Funding
Nov 4, 2024
Total Funding Raised
$10.25M
Company Overview
Interna Therapeutics is a biotechnology company that develops a universal intracellular delivery platform based on its proprietary Molecular Nano Motor (MNM) technology for the delivery of macromolecule drugs.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Interna Therapeutics Comparables
Compare Interna Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| CyGenica | 85% | |
| Sapreme Technologies BV | 83% | |
| Permeasis Therapeutics | 80% |
Interna Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Early Funding | Nov 4, 2024 |
Key People
Founding team and executive leadership
Interna Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Gates Foundation | Early Funding |
Market signals
Structured signals derived from secondary market and firmographic data.
- Mar 3, 2026
Monthly visitors grew 169% MoM, reaching 2.8K.
Interna Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Interna Therapeutics's valuation, stock price, and market status.
Is Interna Therapeutics a public or private company?
Interna Therapeutics is a private company.
What is the current stock price of Interna Therapeutics?
Interna Therapeutics is a private company with no public stock price. No recent secondary market data is available.
How much is Interna Therapeutics worth (valuation)?
Valuation information for Interna Therapeutics is not publicly available.
Can I buy Interna Therapeutics stock?
Interna Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Interna Therapeutics's last funding round?
Interna Therapeutics's most recent funding round was Early Funding on November 4, 2024.
Who are the main investors in Interna Therapeutics?
Key investors in Interna Therapeutics include Gates Foundation.
Will Interna Therapeutics IPO soon?
No public IPO plans have been announced for Interna Therapeutics.
How can I track Interna Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Interna Therapeutics's secondary market activity and sign up for updates.